• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.62% Nasdaq Up 0.35%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NasdaqGM
    5.41 Down 0.03(0.55%) Feb 10, 4:00PM EST
    Prev Close:5.44
    Open:5.50
    Bid:5.15 x 200
    Ask:10.14 x 500
    1y Target Est:14.00
    Beta:1.33576
    Earnings Date:Feb 22 - Feb 26 (Est.)
    Day's Range:5.40 - 5.79
    52wk Range:5.10 - 13.84
    Volume:1,341,981
    Avg Vol (3m):1,403,010
    Market Cap:625.26M
    P/E (ttm):N/A
    EPS (ttm):-1.01
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MACK

    Comparison

    Symbol% ChgMkt Cap
    MACKDown 0.55%625.26M
    THLDDown 0.60%20.03M
    IMMUDown 4.35%187.59M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.18
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.17
    Quarterly EPS Est (Dec-15) :-0.25
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-0.98

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback